Isabella C. Glitza, MD, discusses a single-center phase I/Ib trial of concurrent intravenous and intrathecal nivolumab for patients with metastatic melanoma and leptomeningeal disease.
Isabella C. Glitza, MD
Advertisement
Articles by Isabella C. Glitza, MD
Advertisement
Latest Updated Articles
Dr. Glitza on Intrathecal Nivolumab Approaches in Leptomeningeal DiseaseNovember 23rd 2019
Advertisement
Advertisement
Trending on OncLive
1
Triplet Immunotherapy Regimen Yields Durable Responses in pMMR CRPC
2
Talk of Cure, a New ADC, and a Negative Trial: Breaking Down the Biggest Gynecologic Cancer News From ASCO 2026
3
FDA-Approved ADCs Prompt the Need for Revisions to the Breast Cancer Management Roadmap
4
Phase 1 Data Set the Stage for Further Exploration of Cevostamab in R/R Myeloma
5